Showing results (381-390 of 536) with videos related to

Sort By:
Pageof 54
International Journal of Cancer|June 28, 2016
A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variantsAmaury Vaysse, Shenying Fang, Myriam Brossard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic CancerCaitlin A Hester, Giampaolo Perri, Laura R Prakash, et al.
Annals of Surgical Oncology|February 15, 2013
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysisChing-Wei D Tzeng, Daniel E Abbott, Scott B Cantor, et al.
Histopathology|May 7, 2015
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomyLaurice K Fischer, Matthew H Katz, Sun M Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 2, 2019
Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticatorEduardo A Vega, Eduardo Vinuela, Marcel Sanhueza, et al.
Cancer|May 19, 2012
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicatorsMatthew H G Katz, Jason B Fleming, Priya Bhosale, et al.
Pharmacogenetics and Genomics|March 16, 2006
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanomaChunying Li, Derek Larson, Zhengdong Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysisChunying Li, Zhibin Hu, Zhensheng Liu, et al.
Pancreas|June 19, 2019
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOXTimothy J Vreeland, Florencia McAllister, Sanaz Javadi, et al.
Annals of Surgical Oncology|April 8, 2018
Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver MetastasesJordan M Cloyd, Kiyohiko Omichi, Takashi Mizuno, et al.
Pageof 54